Balanced news tone
News Sentiment
COV sentiment intelligence
Cleo Diagnostics Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
92/100 classification confidence.
directly relevant articles
high-authority source matches
+2.0% over one week, +0.0% over four weeks, trend inactive, and materially above fair value.
Cleo Diagnostics (ASX:COV) Shares Fall: Is the Pullback Putting the Cancer-Diagnostics Stock on the Watchlist?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Cleo Diagnostics (ASX:COV) Shares Fall: Is the Pullback Putting the Cancer-Diagnostics Stock on the Watchlist?
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 13 Jul 2026 07:14
- Source
- Kalkine
CLEO Diagnostics (ASX:COV) Slips as ASX Biotech Volatility Stays in Focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 13:15
- Source
- Kalkine
CLEO Diagnostics Director Restructures Holding of Unlisted Options
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:02
- Source
- TipRanks
Why Has Cleo Diagnostics (ASX:COV) Gained Nearly 27% Over the Past Year?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Kalkine
CLEO Diagnostics (ASX:COV) Is Under Pressure. Here’s a Possible Explanation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Kalkine
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
We Think Cleo Diagnostics (ASX:COV) Can Easily Afford To Drive Business Growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Apr 2026 07:00
- Source
- Market source
Companies Like Cleo Diagnostics (ASX:COV) Are In A Position To Invest In Growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Sep 2025 07:00
- Source
- simplywall.st
Cleo Diagnostics Stock Price, News, Quote & History
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Nov 2023 16:55
- Source
- Investing News Network
Cleo Diagnostics Ltd (ASX: COV) - Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Aug 2023 20:37
- Source
- intelligentinvestor.com.au
Technical Analysis of CLEO Diagnostics Ltd (ASX:COV)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Aug 2023 04:52
- Source
- TradingView
COV Stock Price and Chart — ASX:COV
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Aug 2023 04:51
- Source
- TradingView